These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The evidence for interleukin-6 as an autocrine growth factor in malignancy. Akira S; Kishimoto T Semin Cancer Biol; 1992 Feb; 3(1):17-26. PubMed ID: 1643291 [TBL] [Abstract][Full Text] [Related]
3. Biological and clinical aspects of interleukin 6. Hirano T; Akira S; Taga T; Kishimoto T Immunol Today; 1990 Dec; 11(12):443-9. PubMed ID: 2127356 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6: discovery of a pleiotropic cytokine. Kishimoto T Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S2. PubMed ID: 16899106 [TBL] [Abstract][Full Text] [Related]
6. [Basic and clinical aspects of IL-6]. Nakajima K; Hirano T Gan To Kagaku Ryoho; 1991 Apr; 18(4):505-14. PubMed ID: 1707253 [TBL] [Abstract][Full Text] [Related]
7. Role of a two-chain IL-6 receptor system in immune and hematopoietic cell regulation. Taga T; Kishimoto T Crit Rev Immunol; 1992; 11(5):265-80. PubMed ID: 1642780 [TBL] [Abstract][Full Text] [Related]
8. Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias. Hirano T Int J Cell Cloning; 1991 May; 9(3):166-84. PubMed ID: 2061619 [TBL] [Abstract][Full Text] [Related]
9. A multifunctional cytokine (IL-6/BSF-2) and its receptor. Hirano T; Taga T; Yamasaki K; Matsuda T; Tang B; Muraguchi A; Horii Y; Suematsu S; Hirata Y; Yawata H Int Arch Allergy Appl Immunol; 1989; 88(1-2):29-33. PubMed ID: 2651317 [TBL] [Abstract][Full Text] [Related]
10. Receptors for interleukin 4, interleukin 5 and interleukin 6. Banchereau J; Galizzi JP Ann Ist Super Sanita; 1990; 26(3-4):453-67. PubMed ID: 2091506 [TBL] [Abstract][Full Text] [Related]
11. [Interleukin-2 signaling pathway regulating molecules in systemic lupus erythematosus]. Guo Q; Chen XY; Su Y Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1100-1104. PubMed ID: 27987522 [TBL] [Abstract][Full Text] [Related]
14. IL-6: from laboratory to bedside. Kishimoto T Clin Rev Allergy Immunol; 2005 Jun; 28(3):177-86. PubMed ID: 16129902 [TBL] [Abstract][Full Text] [Related]
15. Regulation of pre-B cell colony-enhancing factor by STAT-3-dependent interleukin-6 trans-signaling: implications in the pathogenesis of rheumatoid arthritis. Nowell MA; Richards PJ; Fielding CA; Ognjanovic S; Topley N; Williams AS; Bryant-Greenwood G; Jones SA Arthritis Rheum; 2006 Jul; 54(7):2084-95. PubMed ID: 16802343 [TBL] [Abstract][Full Text] [Related]
16. The biology and medical implications of interleukin-6. Tanaka T; Kishimoto T Cancer Immunol Res; 2014 Apr; 2(4):288-94. PubMed ID: 24764575 [TBL] [Abstract][Full Text] [Related]
17. A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy. Tanaka T; Narazaki M; Ogata A; Kishimoto T Semin Immunol; 2014 Feb; 26(1):88-96. PubMed ID: 24594001 [TBL] [Abstract][Full Text] [Related]
18. The role of interferon-beta 1 and the 26-kDa protein (interferon-beta 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. Van Damme J; De Ley M; Van Snick J; Dinarello CA; Billiau A J Immunol; 1987 Sep; 139(6):1867-72. PubMed ID: 3305707 [TBL] [Abstract][Full Text] [Related]
19. Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). Akira S; Hirano T; Taga T; Kishimoto T FASEB J; 1990 Aug; 4(11):2860-7. PubMed ID: 2199284 [TBL] [Abstract][Full Text] [Related]
20. Gene regulation by interleukin 6. Fey GH; Hattori M; Hocke G; Brechner T; Baffet G; Baumann M; Baumann H; Northemann W Biochimie; 1991 Jan; 73(1):47-50. PubMed ID: 2031958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]